Home / Treatment Library / Evolysse™
Structure, contour and balance. A clear, evidence-aware guide to candidacy, treatment, recovery, limitations and next steps.
Your anatomy, expression and goals guide every recommendation—so the result still feels unmistakably like you.
Evolysse™ is an FDA-approved hyaluronic-acid dermal filler family that includes Smooth and Form. It may be selected to restore or refine facial volume when the product’s approved indication, tissue characteristics and your anatomy align. FDA approval covers dermal and subdermal injection for moderate-to-severe dynamic facial wrinkles and folds, such as nasolabial folds, in adults age 22 and older.
Adults with moderate-to-severe dynamic facial wrinkles and folds, such as nasolabial folds, who want a hyaluronic-acid option. Evolysse is FDA-approved for dermal and subdermal injection in adults aged 22 and over. As a newer product family it has a shorter real-world track record than the longest-established gels, which is a reasonable thing to weigh rather than something to talk you out of.
Treatment may be postponed for active skin or dental infection, inflammation near the treatment area, pregnancy or breastfeeding, or uncontrolled medical conditions. Severe allergies, bleeding risk, immune-modifying medicines, prior filler and planned dental work must be discussed. Product-specific contraindications apply.
These are practical planning ranges, not promises. Your consultation determines the exact plan.
The provider checks that what you want treated matches what the selected Evolysse product is approved for — dynamic wrinkles and folds — and discusses the alternatives honestly, including established products.
Approval covers dermal and subdermal injection. Gel is placed at the depth the area calls for, in small amounts, reassessing as it goes.
The area is reassessed for symmetry and circulation, with written aftercare and urgent warning signs. Durability varies by product, area and patient, so maintenance is planned individually.
Common effects include swelling, tenderness, bruising, redness, firmness, lumps or asymmetry. Rare injection into a blood vessel can cause skin injury, scarring, stroke, vision changes or blindness. Delayed inflammation, infection, nodules and product migration can occur, and some complications may be permanent. Evolysse is a hyaluronic-acid gel, so hyaluronidase can dissolve it if that becomes necessary. Its clinical durability varies by product and by patient, and anyone quoting you a fixed number of months is guessing.
Safe filler treatment depends on detailed knowledge of facial vessels, tissue planes and product behavior. Experienced providers use conservative planning, maintain an emergency protocol and know when not to inject—or when referral or surgery is the better option.
Consultation and treatment are in-office. Telehealth may be used for general education, but product selection and injections require an in-person examination.
Pricing: Consultation required. Cost depends on product, treatment area, amount and whether a staged plan is safest. Exact pricing is confirmed before treatment.
Medical-content evidence review: July 30, 2026. Content is written for patient education and structured from current primary regulatory, labeling and professional sources. It has not been individualized to your medical history. Product labeling and guidance can change; a licensed Identity Aesthetics provider confirms current suitability, informed consent and treatment details before care.
Bring your goals, questions, medication list and prior treatment history. We will help you decide whether Evolysse™—or an alternative—makes sense.
